Spillover effects of state medicaid antipsychotic prior authorization policies in US commercially insured youth.
O'Mareen SpenceGloria ReevesSusan dosReisPublished in: Pharmacoepidemiology and drug safety (2020)
While Medicaid PA polices for antipsychotic oversight did not affect overall prescribing, there were spillover effects in U.S. commercially insured children <12 years-old. This suggests that state-level Medicaid policies intended to improve the quality of care and safe use of antipsychotics can have broad reach.